Literature DB >> 30916408

Implementation of a new separation method to produce qualitatively improved 64 Cu.

Nicholas P van der Meulen1,2, Roger Hasler2, Alain Blanc2, Renata Farkas2, Martina Benešová2,3, Zeynep Talip2, Cristina Müller2,3, Roger Schibli2,3.   

Abstract

BACKGROUND: 64 Cu (T1/2  = 12.7 h) is an important radionuclide for diagnostic purposes and used for positron emission tomography (PET). A previous method utilized at Paul Scherrer Institute (PSI) proved to be unreliable and, while a method using anion exchange chromatography is a popular choice worldwide, it was felt a different approach was required to obtain a robust chemical separation method.
METHODS: Enriched 64 Ni targets were created by electroplating on gold foil. The targets were irradiated with protons degraded to approximately 11 MeV at PSI's Injector 2 72 MeV research cyclotron and subsequently dissolved in HCl. The resultant solution was loaded onto AG MP-50 cation exchange resin and the 64 Cu separated from its target material and radiocobalt impurities, produced as part of the irradiation process, using various specific mixtures of HCl/acetone solution. The eluted product was evaporated and picked up in dilute HCl (0.05 M). The chemical purity of 64 Cu was determined by radiolabeling experiments at the highest possible molar activities.
RESULTS: Reproducible results were obtained, yielding 3.6 to 8.3 GBq 64 Cu of high radionuclidic and radiochemical purity. The product was labeled to NODAGA-RGD, achieved at up to 500 MBq/nmol, indicating the high chemical purity. In a proof-of-concept in vivo study, 64 Cu-NODAGA-RGD was used for PET imaging of a tumor-bearing mouse.
CONCLUSION: The chemical separation devised to produce high-quality 64 Cu proved to be robust and reproducible. The concept can be used at medical cyclotrons utilizing a solid target station, such that 64 Cu can be used at hospitals for PET imaging.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30916408     DOI: 10.1002/jlcr.3730

Source DB:  PubMed          Journal:  J Labelled Comp Radiopharm        ISSN: 0362-4803            Impact factor:   1.921


  3 in total

1.  Chelation of Theranostic Copper Radioisotopes with S-Rich Macrocycles: From Radiolabelling of Copper-64 to In Vivo Investigation.

Authors:  Marianna Tosato; Marco Verona; Chiara Favaretto; Marco Pometti; Giordano Zanoni; Fabrizio Scopelliti; Francesco Paolo Cammarata; Luca Morselli; Zeynep Talip; Nicholas P van der Meulen; Valerio Di Marco; Mattia Asti
Journal:  Molecules       Date:  2022-06-28       Impact factor: 4.927

2.  Highly Efficient Separation of Ultratrace Radioactive Copper Using a Flow Electrolysis Cell.

Authors:  Yumi Sugo; Shin-Ichi Ohira; Hinako Manabe; Yo-Hei Maruyama; Naoaki Yamazaki; Ryoma Miyachi; Kei Toda; Noriko S Ishioka; Masanobu Mori
Journal:  ACS Omega       Date:  2022-04-27

Review 3.  Production Review of Accelerator-Based Medical Isotopes.

Authors:  Yiwei Wang; Daiyuan Chen; Ricardo Dos Santos Augusto; Jixin Liang; Zhi Qin; Juntao Liu; Zhiyi Liu
Journal:  Molecules       Date:  2022-08-19       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.